ATC code B02

ATC code B02 Antihemorrhagics is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.^[1][2][3] Subgroup B02 is part of the anatomical group B Blood and blood forming organs.^[4]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QB02.^[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

B02A Antifibrinolytics

B02AA Amino acids

B02AA01 Aminocaproic acid

B02AA02 Tranexamic acid

B02AA03 Aminomethylbenzoic acid

B02AB Proteinase inhibitors

B02AB01 Aprotinin

B02AB02 Alfa1 antitrypsin

B02AB04 Camostat

B02AB05 Ulinastatin

B02B Vitamin K and other hemostatics

B02BA Vitamin K

B02BA01 Phytomenadione

B02BA02 Menadione

B02BB Fibrinogen

B02BB01 Human fibrinogen

B02BC Local hemostatics

B02BC01 Absorbable gelatin sponge

B02BC02 Oxidized cellulose

B02BC03 Tetragalacturonic acid hydroxymethylester

B02BC05 Adrenalone

B02BC06 Thrombin

B02BC07 Collagen

B02BC08 Calcium alginate

B02BC09 Epinephrine

B02BC30 Combinations

B02BD Blood coagulation factors

B02BD01 Coagulation factor IX, II, VII and X in combination (Prothrombin complex concentrate)

B02BD02 Coagulation factor VIII

B02BD03 Factor VIII inhibitor bypassing activity

B02BD04 Coagulation factor IX

B02BD05 Coagulation factor VII

B02BD06 von Willebrand factor and coagulation factor VIII in combination

B02BD07 Coagulation factor XIII

B02BD08 Coagulation factor VIIa

B02BD10 von Willebrand factor

B02BD11 Catridecacog

B02BD13 Coagulation factor X

B02BD14 Susoctocog alfa

B02BD15 Valoctocogene roxaparvovec

B02BD16 Etranacogene dezaparvovec

B02BD17 Fidanacogene elaparvovec

B02BD30 Thrombin

B02BX Other systemic hemostatics

B02BX01 Etamsylate

B02BX02 Carbazochrome

B02BX03 Batroxobin

B02BX04 Romiplostim

B02BX05 Eltrombopag

B02BX06 Emicizumab

B02BX07 Lusutrombopag

B02BX08 Avatrombopag

B02BX09 Fostamatinib

B02BX10 Concizumab

B02BX11 Marstacimab

References

1. "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
2. World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
3. "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
4. "ATC/DDD Index 2022: code B02". WHO Collaborating Centre for Drug Statistics Methodology.
5. "ATCvet Index 2022: code QB02". WHO Collaborating Centre for Drug Statistics Methodology.